These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9590653)

  • 1. A neutralizing anti-TGF-beta1 antibody promotes proliferation of CD34+Thy-1+ peripheral blood progenitors and increases the number of transduced progenitors.
    Imbert AM; Bagnis C; Galindo R; Chabannon C; Mannoni P
    Exp Hematol; 1998 May; 26(5):374-81. PubMed ID: 9590653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p21(cip1) mRNA is controlled by endogenous transforming growth factor-beta1 in quiescent human hematopoietic stem/progenitor cells.
    Ducos K; Panterne B; Fortunel N; Hatzfeld A; Monier MN; Hatzfeld J
    J Cell Physiol; 2000 Jul; 184(1):80-5. PubMed ID: 10825236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release from quiescence of primitive human hematopoietic stem/progenitor cells by blocking their cell-surface TGF-beta type II receptor in a short-term in vitro assay.
    Fortunel N; Hatzfeld J; Kisselev S; Monier MN; Ducos K; Cardoso A; Batard P; Hatzfeld A
    Stem Cells; 2000; 18(2):102-11. PubMed ID: 10742382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.
    Hematti P; Tuchman S; Larochelle A; Metzger ME; Donahue RE; Tisdale JF
    Stem Cells; 2004; 22(6):1062-9. PubMed ID: 15536196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the nlsLacz gene in dendritic cells derived from retrovirally transduced peripheral blood CD34+ cells.
    Chischportich C; Bagnis C; Galindo R; Mannoni P
    Haematologica; 1999 Mar; 84(3):195-203. PubMed ID: 10189381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogation of TGF-beta activity during retroviral transduction improves murine hematopoietic progenitor and repopulating cell gene transfer efficiency.
    Yu J; Soma T; Hanazono Y; Dunbar CE
    Gene Ther; 1998 Sep; 5(9):1265-71. PubMed ID: 9930329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Special susceptibility to apoptosis of CD1a+ dendritic cell precursors differentiating from cord blood CD34+ progenitors.
    Canque B; Camus S; Yagello M; Gluckman JC
    Stem Cells; 1998; 16(3):218-28. PubMed ID: 9617897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.
    Shields LE; Kiem HP; Andrews RG
    Am J Obstet Gynecol; 2000 Sep; 183(3):732-7. PubMed ID: 10992201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth factors increase retroviral transduction but decrease clonogenic potential of umbilical cord blood CD34+ cells.
    Corrias MV; Scuderi F; Pasino M; Biglino P; Bocca P; Marotta F; Figini E; Pistoia V; Mori PG
    Haematologica; 1998 Jul; 83(7):580-6. PubMed ID: 9718861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression.
    Villaron EM; Almeida J; Lopez-Holgado N; Sanchez-Guijo FM; Alberca M; Blanco B; Sanchez-Abarca LI; Lopez O; Perez-Simon JA; San Miguel JF; del Cañizo MC
    Transfus Apher Sci; 2007 Oct; 37(2):145-56. PubMed ID: 17983836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The high proliferative potential-quiescent (HPP-Q) cell assay allows an optimized evaluation of gene transfer efficiency into primitive hematopoietic stem/progenitor cells.
    Ducos K; Hatzfeld A; Héron A; Fortunel N; Kisselev S; Héron C; Monier MN; Hatzfeld J
    Gene Ther; 2000 Oct; 7(20):1790-4. PubMed ID: 11083502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased gene transfer into human CD34+ progenitor cells using retroviral vectors produced by a canine packaging cell line.
    Bauer G; Sauter S; Ibanez C; Rice CR; Valdez P; Jolly D; Kohn DB
    Biol Blood Marrow Transplant; 1998; 4(3):119-27. PubMed ID: 9923409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus and retrovirus mediated interferon alpha gene transfer into CD34+ cells maintains regeneration capacity and enhances adhesion molecules in K562 cells.
    Seiter K; Kancherla R; Yang L; Quan S; Farley TJ; Abraham NG; Ahmed T
    J Investig Med; 1999 Sep; 47(8):414-24. PubMed ID: 10510594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.
    Cornetta K; Croop J; Dropcho E; Abonour R; Kieran MW; Kreissman S; Reeves L; Erickson LC; Williams DA
    Cancer Gene Ther; 2006 Sep; 13(9):886-95. PubMed ID: 16645619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of peripheral blood CD34+ cells mobilized with granulocyte colony-stimulating factor (G-CSF) using a long-term culture system.
    Suzuki T; Muroi K; Amemiya Y; Miura Y
    Bone Marrow Transplant; 1998 Apr; 21(8):751-7. PubMed ID: 9603397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of natural killer cells in the presence of CD34+ blood progenitor cells and peripheral blood lymphocytes.
    Clausen J; Enk M; Vergeiner B; Eisendle K; Petzer AL; Gastl G; Gunsilius E
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):691-7. PubMed ID: 15389435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV.
    Nathwani AC; Hanawa H; Vandergriff J; Kelly P; Vanin EF; Nienhuis AW
    Gene Ther; 2000 Feb; 7(3):183-95. PubMed ID: 10694794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.